{"id":"doi:10.1016/s0140-6736(16)31009-1","kind":"article","title":"Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials","authors":["Nicholas J. Viney","Julian C. van Capelleveen","Richard S. Geary","Shuting Xia","Joseph A. Tami","Rosie Z. Yu","Santica M. Marcovina","Steven G. Hughes","Mark J. Graham","Rosanne M. Crooke","Stanley T. Crooke","Joseph Lee Witztum","Erik S.G. Stroes","Sotirios Tsimikas"],"author_count":14,"year":2016,"published":"2016-09-21","venue":"The Lancet","cited_by":753,"doi":"10.1016/s0140-6736(16)31009-1","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/s0140-6736(16)31009-1","archive_url":"https://space-kitty.com/papers/doi:10.1016/s0140-6736(16)31009-1","updated":null,"pmid":"27665230","pmcid":null,"openalex_id":"W2522418769","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Lipoproteins and Cardiovascular Health"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","domain_slug":"medicine"}],"cited_in_dossiers":[]}